Anemia Treatment Drugs -Global Market Status and Trend Report 2013-2023

Table of Contents

Chapter 1 Overview of Anemia Treatment Drugs

• 1.1 Definition of Anemia Treatment Drugs in This Report
• 1.2 Commercial Types of Anemia Treatment Drugs
  • 1.2.1 Supplements
  • 1.2.2 Antibiotics
  • 1.2.3 Immunosuppressant
  • 1.2.4 Bone Marrow Stimulants
  • 1.2.5 Corticosteroids
  • 1.2.6 Gene Therapy
  • 1.2.7 Iron Chelating Agents
• 1.3 Downstream Application of Anemia Treatment Drugs
  • 1.3.1 Iron deficiency anemia
  • 1.3.2 Thalassemia
  • 1.3.3 Aplastic anemia
  • 1.3.4 Hemolytic anemia
  • 1.3.5 Sickle cell anemia
  • 1.3.6 Pernicious anemia
• 1.4 Development History of Anemia Treatment Drugs
• 1.5 Market Status and Trend of Anemia Treatment Drugs 2013-2023
  • 1.5.1 Global Anemia Treatment Drugs Market Status and Trend 2013-2023
  • 1.5.2 Regional Anemia Treatment Drugs Market Status and Trend 2013-2023

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Anemia Treatment Drugs 2013-2017
• 2.2 Production Market of Anemia Treatment Drugs by Regions
  • 2.2.1 Production Volume of Anemia Treatment Drugs by Regions
  • 2.2.2 Production Value of Anemia Treatment Drugs by Regions
• 2.3 Demand Market of Anemia Treatment Drugs by Regions
• 2.4 Production and Demand Status of Anemia Treatment Drugs by Regions
  • 2.4.1 Production and Demand Status of Anemia Treatment Drugs by Regions 2013-2017
  • 2.4.2 Import and Export Status of Anemia Treatment Drugs by Regions 2013-2017

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Anemia Treatment Drugs by Types
• 3.2 Production Value of Anemia Treatment Drugs by Types
• 3.3 Market Forecast of Anemia Treatment Drugs by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Anemia Treatment Drugs by Downstream Industry
• 4.2 Market Forecast of Anemia Treatment Drugs by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Anemia Treatment Drugs

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Anemia Treatment Drugs Downstream Industry Situation and Trend Overview

Chapter 6 Anemia Treatment Drugs Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Anemia Treatment Drugs by Major Manufacturers
• 6.2 Production Value of Anemia Treatment Drugs by Major Manufacturers
• 6.3 Basic Information of Anemia Treatment Drugs by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Anemia Treatment Drugs Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Anemia Treatment Drugs Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Anemia Treatment Drugs Major Manufacturers Introduction and Market Data

• 7.1 Bayer AG
  • 7.1.1 Company profile
  • 7.1.2 Representative Anemia Treatment Drugs Product
  • 7.1.3 Anemia Treatment Drugs Sales, Revenue, Price and Gross Margin of Bayer AG
• 7.2 AMAG Pharmaceuticals
  • 7.2.1 Company profile
  • 7.2.2 Representative Anemia Treatment Drugs Product
  • 7.2.3 Anemia Treatment Drugs Sales, Revenue, Price and Gross Margin of AMAG Pharmaceuticals
• 7.3 Merck Sharp & Dohme Corp.
  • 7.3.1 Company profile
  • 7.3.2 Representative Anemia Treatment Drugs Product
  • 7.3.3 Anemia Treatment Drugs Sales, Revenue, Price and Gross Margin of Merck Sharp & Dohme Corp.
• 7.4 Amgen, Inc.
  • 7.4.1 Company profile
  • 7.4.2 Representative Anemia Treatment Drugs Product
  • 7.4.3 Anemia Treatment Drugs Sales, Revenue, Price and Gross Margin of Amgen, Inc.
• 7.5 Pfizer, Inc.
  • 7.5.1 Company profile
  • 7.5.2 Representative Anemia Treatment Drugs Product
  • 7.5.3 Anemia Treatment Drugs Sales, Revenue, Price and Gross Margin of Pfizer, Inc.
• 7.6 Hoffmann-La Roche Ltd.
  • 7.6.1 Company profile
  • 7.6.2 Representative Anemia Treatment Drugs Product
  • 7.6.3 Anemia Treatment Drugs Sales, Revenue, Price and Gross Margin of Hoffmann-La Roche Ltd.
• 7.7 Akebia Therapeutics
  • 7.7.1 Company profile
  • 7.7.2 Representative Anemia Treatment Drugs Product
  • 7.7.3 Anemia Treatment Drugs Sales, Revenue, Price and Gross Margin of Akebia Therapeutics
• 7.8 Janssen Pharmaceutical
  • 7.8.1 Company profile
  • 7.8.2 Representative Anemia Treatment Drugs Product
  • 7.8.3 Anemia Treatment Drugs Sales, Revenue, Price and Gross Margin of Janssen Pharmaceutical
• 7.9 Novartis AG
  • 7.9.1 Company profile
  • 7.9.2 Representative Anemia Treatment Drugs Product
  • 7.9.3 Anemia Treatment Drugs Sales, Revenue, Price and Gross Margin of Novartis AG
• 7.10 GlaxoSmithKline plc
  • 7.10.1 Company profile
  • 7.10.2 Representative Anemia Treatment Drugs Product
  • 7.10.3 Anemia Treatment Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline plc
• 7.11 Vifor Pharma Management, Ltd.
  • 7.11.1 Company profile
  • 7.11.2 Representative Anemia Treatment Drugs Product
  • 7.11.3 Anemia Treatment Drugs Sales, Revenue, Price and Gross Margin of Vifor Pharma Management, Ltd.
• 7.12 FibroGen, Inc.
  • 7.12.1 Company profile
  • 7.12.2 Representative Anemia Treatment Drugs Product
  • 7.12.3 Anemia Treatment Drugs Sales, Revenue, Price and Gross Margin of FibroGen, Inc.

Chapter 8 Upstream and Downstream Market Analysis of Anemia Treatment Drugs

• 8.1 Industry Chain of Anemia Treatment Drugs
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Anemia Treatment Drugs

• 9.1 Cost Structure Analysis of Anemia Treatment Drugs
• 9.2 Raw Materials Cost Analysis of Anemia Treatment Drugs
• 9.3 Labor Cost Analysis of Anemia Treatment Drugs
• 9.4 Manufacturing Expenses Analysis of Anemia Treatment Drugs

Chapter 10 Marketing Status Analysis of Anemia Treatment Drugs

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources